GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. is a global medical technology company that designs, manufactures, and services imaging equipment, ultrasound systems, patient monitoring devices, and pharmaceutical diagnostic agents, generating $20.6 billion in revenue in fiscal 2025. Spun off from GE Aerospace in January 2023, the company operates across four reportable segments — Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx) — though it reorganized into three segments (combining Imaging and AVS into Advanced Imaging Solutions, or AIS) effective January 2026.

This is a story about an incumbent industrial franchise funding one of the most ambitious innovation cycles in its history while fighting a multi-front war against tariffs, Chinese competition, and input-cost inflation. The company's installed base of imaging equipment, its PDx franchise, and its ~$10.9 billion services backlog provide a durable earnings floor. The question is whether the new-product pipeline — Photon Counting CT, Flyrcado, next-generation MR, a novel manganese-based contrast agent — can re-accelerate growth and margins enough to overcome the headwinds that compressed them in 2025. The file turns on a single judgment: whether the innovation flywheel is real, and whether it engages before the tariff and competitive pressures do permanent damage to returns.